Day One Biopharmaceuticals, Inc. — All Filings
457 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC 14D9
SC TO-C
SC TO-T
SC TO-T/A
SC14D9C
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 10-K/A | 10-K/A | 0000950170-25-034878 | Mar 6, 2025 | Dec 31, 2024 |
| 3 | — | 0001415889-25-006071 | Feb 28, 2025 | Feb 26, 2025 |
| 8-K | 8-K | 0000950170-25-026632 | Feb 25, 2025 | — |
| 10-K | 10-K | 0000950170-25-026654 | Feb 25, 2025 | Dec 31, 2024 |
| 4 | — | 0001415889-25-005159 | Feb 21, 2025 | Feb 15, 2025 |
| 4 | — | 0001415889-25-005157 | Feb 21, 2025 | Feb 15, 2025 |
| 4 | — | 0001415889-25-005154 | Feb 21, 2025 | Feb 15, 2025 |
| 144 | — | 0001950047-25-000994 | Feb 18, 2025 | — |
| 144 | — | 0001950047-25-000995 | Feb 18, 2025 | — |
| 144 | — | 0001950047-25-000996 | Feb 18, 2025 | — |
| SCHEDULE 13G/A | — | 0001415889-25-004277 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000315066-25-000873 | Feb 12, 2025 | — |
| 4 | — | 0001415889-25-002497 | Jan 31, 2025 | Jan 15, 2025 |
| 4 | — | 0001415889-25-002491 | Jan 31, 2025 | Jan 15, 2025 |
| 4 | — | 0001415889-25-002483 | Jan 31, 2025 | Jan 15, 2025 |
| 8-K | 8-K | 0001193125-25-005012 | Jan 13, 2025 | — |
| S-8 | S-8 | 0001193125-25-004434 | Jan 10, 2025 | — |
| 4 | — | 0001415889-24-029085 | Dec 12, 2024 | Dec 10, 2024 |
| 8-K | 8-K | 0001193125-24-262560 | Nov 20, 2024 | — |
| 4 | — | 0001415889-24-027239 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | — | 0001415889-24-027234 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | — | 0001415889-24-027224 | Nov 19, 2024 | Nov 15, 2024 |
| 4 | — | 0001415889-24-027229 | Nov 19, 2024 | Nov 15, 2024 |
| 144 | — | 0001950047-24-008696 | Nov 18, 2024 | — |
| 144 | — | 0001950047-24-008697 | Nov 18, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-119006 | Nov 14, 2024 | — |
| 144 | — | 0001950047-24-008367 | Nov 12, 2024 | — |
| 4 | — | 0001415889-24-026624 | Nov 12, 2024 | Nov 8, 2024 |
| 4 | — | 0001415889-24-026434 | Nov 8, 2024 | Nov 7, 2024 |
| SC 13G | — | 0000315066-24-002574 | Nov 7, 2024 | — |
| SC 13G/A | — | 0000315066-24-002585 | Nov 7, 2024 | — |
| 4 | — | 0001415889-24-026036 | Nov 4, 2024 | Oct 31, 2024 |
| 144 | — | 0001950047-24-007958 | Oct 31, 2024 | — |
| 8-K | 8-K | 0000950170-24-118950 | Oct 30, 2024 | — |
| 10-Q | 10-Q | 0000950170-24-118958 | Oct 30, 2024 | Sep 30, 2024 |
| 4 | — | 0001415889-24-023298 | Sep 12, 2024 | Sep 10, 2024 |
| S-3ASR | S-3ASR | 0001193125-24-208798 | Aug 28, 2024 | — |
| 4 | — | 0001415889-24-021617 | Aug 19, 2024 | Aug 15, 2024 |
| 4 | — | 0001415889-24-021621 | Aug 19, 2024 | Aug 15, 2024 |
| 4 | — | 0001415889-24-021626 | Aug 19, 2024 | Aug 15, 2024 |
| 4 | — | 0001415889-24-021629 | Aug 19, 2024 | Aug 15, 2024 |
| 144 | — | 0001950047-24-006180 | Aug 16, 2024 | — |
| 144 | — | 0001950047-24-006178 | Aug 16, 2024 | — |
| SC 13D/A | SC 13D/A | 0001193125-24-194017 | Aug 5, 2024 | — |
| 4 | 4 | 0000950170-24-090703 | Aug 5, 2024 | Aug 1, 2024 |
| 10-Q | 10-Q | 0000950170-24-089945 | Aug 2, 2024 | Jun 30, 2024 |
| 8-K | 8-K | 0001193125-24-188235 | Jul 30, 2024 | — |
| 8-K | 8-K | 0000950170-24-087505 | Jul 30, 2024 | — |
| 8-K | 8-K | 0001193125-24-184249 | Jul 25, 2024 | Jul 23, 2024 |
| 4 | — | 0001415889-24-019681 | Jul 17, 2024 | Jul 16, 2024 |